APA (7th ed.) Citation

Antin, C., Tauziède-Espariat, A., Debily, M., Castel, D., Grill, J., Pagès, M., . . . Varlet, P. (2020). EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression. Acta Neuropathologica Communications, 8(1), N.PAG. https://doi.org/10.1186/s40478-020-01056-8

Chicago Style (17th ed.) Citation

Antin, C., et al. "EZHIP Is a Specific Diagnostic Biomarker for Posterior Fossa Ependymomas, Group PFA and Diffuse Midline Gliomas H3-WT with EZHIP Overexpression." Acta Neuropathologica Communications 8, no. 1 (2020): N.PAG. https://doi.org/10.1186/s40478-020-01056-8.

MLA (9th ed.) Citation

Antin, C., et al. "EZHIP Is a Specific Diagnostic Biomarker for Posterior Fossa Ependymomas, Group PFA and Diffuse Midline Gliomas H3-WT with EZHIP Overexpression." Acta Neuropathologica Communications, vol. 8, no. 1, 2020, p. N.PAG, https://doi.org/10.1186/s40478-020-01056-8.